1. Home
  2. SNDX vs CCEC Comparison

SNDX vs CCEC Comparison

Compare SNDX & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • CCEC
  • Stock Information
  • Founded
  • SNDX 2005
  • CCEC 2007
  • Country
  • SNDX United States
  • CCEC Greece
  • Employees
  • SNDX N/A
  • CCEC N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • CCEC Marine Transportation
  • Sector
  • SNDX Health Care
  • CCEC Consumer Discretionary
  • Exchange
  • SNDX Nasdaq
  • CCEC Nasdaq
  • Market Cap
  • SNDX 1.1B
  • CCEC 1.1B
  • IPO Year
  • SNDX 2016
  • CCEC 2007
  • Fundamental
  • Price
  • SNDX $13.08
  • CCEC $18.75
  • Analyst Decision
  • SNDX Strong Buy
  • CCEC Buy
  • Analyst Count
  • SNDX 10
  • CCEC 1
  • Target Price
  • SNDX $36.20
  • CCEC $22.00
  • AVG Volume (30 Days)
  • SNDX 2.6M
  • CCEC 16.3K
  • Earning Date
  • SNDX 02-25-2025
  • CCEC 01-31-2025
  • Dividend Yield
  • SNDX N/A
  • CCEC 3.20%
  • EPS Growth
  • SNDX N/A
  • CCEC N/A
  • EPS
  • SNDX N/A
  • CCEC 0.85
  • Revenue
  • SNDX $16,000,000.00
  • CCEC $447,305,000.00
  • Revenue This Year
  • SNDX N/A
  • CCEC $17.05
  • Revenue Next Year
  • SNDX $14.15
  • CCEC $5.68
  • P/E Ratio
  • SNDX N/A
  • CCEC $75.99
  • Revenue Growth
  • SNDX N/A
  • CCEC 29.66
  • 52 Week Low
  • SNDX $12.06
  • CCEC $14.45
  • 52 Week High
  • SNDX $25.34
  • CCEC $20.26
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 41.29
  • CCEC N/A
  • Support Level
  • SNDX $12.40
  • CCEC N/A
  • Resistance Level
  • SNDX $13.16
  • CCEC N/A
  • Average True Range (ATR)
  • SNDX 0.65
  • CCEC 0.00
  • MACD
  • SNDX 0.10
  • CCEC 0.00
  • Stochastic Oscillator
  • SNDX 39.38
  • CCEC 0.00

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About CCEC Capital Clean Energy Carriers Corp. Common Share

Capital Clean Energy Carriers Corp is an international shipping company. It is the leading platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.

Share on Social Networks: